Banco da Amazônia S.A (BAZA3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 76.51 |
|---|---|
| 52-week range | 56.08 – 89.50 |
| Return, 1 month / 3 months | +9.3% / +27.8% |
| Return, 1 year / 3 years | +24.3% / +22.5% |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 37.6% |
| Worst drawdown (1 year) | -25.3% |
| Average daily value traded | 0.26M BRL |
| Dividend yield | 15.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco da Amazônia is a Brazilian bank based in Belém that focuses on financing development in the Amazon region. It provides credit and financial services to rural producers, businesses and public bodies, including rural loans, investment financing and everyday banking through its branch network. Its customers are mainly farmers, cooperatives, companies and local governments in the Amazon states, and it also offers deposit accounts and other commercial banking services to individuals and organisations in the areas it serves.
On this site Banco da Amazônia S.A appears as a stock on the Sao Paulo Exchange (Brazil), code BAZA3, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco da Amazônia S.A (BAZA3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 76.51 on 15 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 277 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 24.3% and over the last three months it rose 27.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 16.2% | ||
| From 52-week high | -14.0% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 27.8% | ||
| 6-month return | 7.9% | ||
| 12-month return, skipping the last month | 13.7% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.3% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.26M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 15.6% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | +9.3% |
| 3 months | +27.8% |
| 6 months | +7.9% |
| 1 year | +24.3% |
| 3 years | +22.5% |
| 5 years | +260.9% |
Signals
| 50-day / 200-day average | 67.72 / 65.85 |
|---|---|
| Golden / death cross (60 days) | Golden, 9 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jun 2026 | BRL 11.9435 |
| 28 Apr 2025 | BRL 8.0123 |
| 26 Apr 2024 | BRL 6.6252 |
| 24 Apr 2023 | BRL 5.3298 |
| 29 Apr 2022 | BRL 6.8700 |
| 22 Apr 2021 | BRL 2.5984 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.